A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Joshua M. Lang(University of Wisconsin–Madison), Anupama Singh(University of Wisconsin–Madison), Nicholas R. Rydzewski(University of Wisconsin–Madison), Kaitlin E. Sundling(University of Wisconsin System), Paul M. Harari(University of Wisconsin Carbone Cancer Center), Wei Huang, Hamza Bakhtiar(University of Wisconsin–Madison), Camila I. Hernandez(University of Wisconsin–Madison), Zachery D. Schultz(University of Wisconsin–Madison), Hannah M. Krause(University of Wisconsin–Madison), Mary‐Ellen Taplin(University of Massachusetts Chan Medical School), Hamid Emamekhoo(University of Wisconsin Carbone Cancer Center), Kyle T. Helzer(University of Wisconsin–Madison), Andrew J. Armstrong(Duke University), Yue Shi(University of Wisconsin–Madison), Xiao X. Wei(Dana-Farber Cancer Institute), Himisha Beltran(Dana-Farber Cancer Institute), Marina N. Sharifi(University of Wisconsin–Madison), Matt Bootsma(University of Wisconsin–Madison), Toni K. Choueiri(Harvard University), Rory M. Bade(University of Wisconsin–Madison), Susan Halabi(Duke Medical Center), Nan Sethakorn(University of Chicago), Richel D. Mayberry(University of Wisconsin System), Menggang Yu(University of Michigan), Jamie M. Sperger(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Christos E. Kyriakopoulos(Dana-Farber Cancer Institute), Grace C. Blitzer(University of Wisconsin–Madison), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Serena K. Wolfe(University of Wisconsin–Madison), David Kosoff(University of Wisconsin–Madison), Jennifer L. Schehr(University of Wisconsin–Madison), Cole S. Gilsdorf(University of Wisconsin–Madison), Charlotte N. Stahlfeld(University of Wisconsin–Madison), David J. Beebe(University of Wisconsin–Madison), John M. Floberg(University of Wisconsin–Madison), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center)
Cited by 33
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k